Trainline Raises Annual Guidance for Second Time in 2026
Inflations Broadening Beyond Oil and Iran These Sectors Show Reaccelerating Price Pressures
Top Economists Forecast Inflation to Reach 6 in Q2 Amid Persistent Price Pressures
SpaceX Successfully Launches Starship in Second Attempt Advancing HeavyLift Capabilities
Companies Maintain Prediction Market Investments Amid Regulatory Uncertainty
Barclays Analyzes Market Implications of Embodied AI Bullish or Bearish
BWA Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus
DOW Q1 2026 Earnings EPS Beats Estimates by 5176 Despite Narrowing Loss
CREX Q1 2026 Earnings EPS Falls Sharply Below Estimates Despite Positive Stock Reaction
Fortis Inc FTS Q1 2026 Earnings Modest EPS Miss Amid Steady Utility Performance
Senseonics Holdings Inc SENS Q1 2026 Earnings Slight EPS Miss but Modest Stock Gains Amid Continued RD Focus
UWMC Q1 2026 Earnings EPS Surprises to the Upside as Mortgage Market Stabilizes
Coffee Holding Co JVA Edges Higher Holds Above Key Support Level
Eaton Vance TaxManaged Diversified Equity Income Fund ETY Edges Higher Amid Cautious Trading
LiqTech International LIQT Edges Lower as Resistance Level Holds Firm
Offerpad Solutions OPAD Rallies 77 to 075 Testing Key Resistance Near 079
Willamette Valley Vineyards WVVI Holds Steady at 267 as Key Support and Resistance Levels Narrow
Indias Consumer Affairs Ministry Probes Cancellation Policies of Online Ticket Platforms
OpenAI Takes the Lead in AI IPO Race Confidential Filing Expected Soon
Trump Administrations 2 Billion Quantum Computing Investment Implications for IBM DWave and Rigetti
AI Disruption Triggers Decline in Vendor Satisfaction Among Channel Partners
Dollar Holds Near SixWeek High as Geopolitical Tensions Over Iran Stir Demand for Safe Havens
Kevin Hassett Highlights Surge in Credit Card Spending Amid Rising Delinquencies and Farm Bankruptcies
Market Expectations Shift Toward Fed Rate Hike After Hot Inflation Data
EH Q4 2025 Earnings Significant EPS Surprise Highlights Progress in eVTOL Commercialization
Rapport Therapeutics RAPP Hovers Near Support Tests Key Level After Mild Decline